Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin lymphoma (NHL)

被引：0
|
作者：
Reiter, A.
Meinhardt, A.
Burkhardt, B.
Zimmermann, M.
Borkhardt, A.
Kontny, U.
Mann, G.
Schrappe, M.
机构：
[1] Childrens Univ Hosp, Giessen, Germany
[2] Univ Childrens Hosp, Kiel, Germany
[3] Hannover Med Sch, D-3000 Hannover, Germany
[4] Univ Childrens Hosp, Dusseldorf, Germany
[5] Univ Childrens Hosp, Freiburg, Germany
[6] St Anna Childrens Hosp, A-1090 Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10000
引用
下载
收藏
页码：CP50 / CP50
页数：1
相关论文
共 50 条
  • [1] Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia
    Meinhardt, Andrea
    Burkhardt, Birgit
    Zimmermann, Martin
    Borkhardt, Arndt
    Kontny, Udo
    Klingebiel, Thomas
    Berthold, Frank
    Janka-Schaub, Gritta
    Klein, Christoph
    Kabickova, Edita
    Klapper, Wolfram
    Attarbaschi, Andishe
    Schrappe, Martin
    Reiter, Alfred
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3115 - 3121
  • [2] Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia: dose-escalation does not increase the response rate
    Lisfeld, J.
    Burkhardt, B.
    Meinhardt, A.
    Zimmermann, M.
    Kabickova, E.
    Bielack, S.
    Kontny, U.
    Gnekow, A.
    Sauerbrey, A.
    Reiter, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 3 - 3
  • [3] Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma
    Toelle, I
    Lanvers-Kaminsky, C.
    Bethke, M.
    Randau, G.
    Rolfi, Ng M.
    Tann, A.
    te Vrugt, M.
    Mellgren, K.
    Mueller, S.
    Burkhardt, B.
    KLINISCHE PADIATRIE, 2023, 235 (03): : 203 - 203
  • [4] Phase II study of oral Fludarabine (FAMP) in combination with rituximab in indolent B-cell non-hodgkin lymphoma (B-NHL)
    Ishizawa, Kenichi
    Tobinai, Kensei
    Ogura, Michinori
    Itoh, Kuniaki
    Aorishima, Yasuo
    Ando, Kiyoshi
    Yamamoto, Joji
    Watanabe, Takashi
    Uchida, Toshiki
    Nakata, Masanobu
    Hayashi, Masaki
    Hotta, Tomomitsu
    BLOOD, 2007, 110 (11) : 387A - 387A
  • [5] Patient parameters and response after administration of rituximab in pediatric mature B-cell non-Hodgkin lymphoma
    Bethke, Maria
    Varga, Georg
    Weinhage, Toni
    Sabharwal, Harshana
    Mellgren, Karin
    Randau, Gerrit
    Rolfing, Meike
    Wittkowski, Helmut
    Foell, Dirk
    Michgehl, Ulf
    Burkhardt, Birgit
    PEDIATRIC BLOOD & CANCER, 2022, 69 (04)
  • [6] RITUXIMAB CLEARANCE IN PEDIATRIC PATIENTS WITH MAATURE B-CELL NON-HODGKIN LYMPHOMA
    Toelle, I.
    Lanvers-Kaminsky, C.
    Bethke, M.
    Randau, G.
    Rolfing, M.
    Tann, A.
    te Vrugt, M.
    Mellgren, K.
    Mueller, S.
    Burkhardt, B.
    LEUKEMIA RESEARCH, 2022, 121 : S23 - S24
  • [7] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Taniwaki, M.
    Ogura, M.
    Matsumoto, Y.
    Uchida, T.
    Ohmachi, K.
    Ando, K.
    Watanabe, T.
    Tobinai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Phase I study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin's lymphoma (NHL).
    Ansell, SM
    Witzig, TE
    Kurtin, PJ
    Jelinek, DF
    Howell, KG
    Markovic, SN
    Habermann, TM
    Klee, GG
    Sloan, JA
    Erlichmann, C
    BLOOD, 2000, 96 (11) : 577A - +
  • [9] Application of the international pediatric Non-Hodgkin lymphoma staging system (IPNHLSS) to pediatric patients newly diagnosed with B-cell Non-Hodgkin's lymphoma (B-NHL) enrolled in the AIEOP LNH-97 protocol
    Onofrillo, Daniela
    Pascale, Silvia
    Carraro, Elisa
    Massano, Davide
    Mussolin, Lara
    Mura, Rosamaria
    Vinti, Luciana
    Buffardi, Salvatore
    Farruggia, Piero
    Cesaro, Simone
    Tolva, Alessandra
    Bertolini, Patrizia
    Piglione, Matilde
    Tondo, Annalisa
    Santoro, Nicola
    Garaventa, Alberto
    Lo Nigro, Luca
    Sala, Alessandra
    Pillon, Marta
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 39 - 40
  • [10] A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
    Chen, Robert
    Frankel, Paul
    Popplewell, Leslie
    Siddiqi, Tanya
    Ruel, Nora
    Rotter, Arnold
    Thomas, Sandra H.
    Mott, Michelle
    Nathwani, Nitya
    Htut, Myo
    Nademanee, Auayporn
    Forman, Stephen J.
    Kirschbaum, Mark
    HAEMATOLOGICA, 2015, 100 (03) : 357 - 362
12345